Nexplanon 68 MG implants

Ended Awarded Last action

Contract number
SPE2DR26FRRW5
Awardee
Awarding agency
Obligated
$10,058

Award facts

Contract value 100% obligated
$10,057.68 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $10,057.68 delivery order to DMS Pharmaceutical Group Inc. on March 20, 2026, for Nexplanon 68 mg implants.

The order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling through December 31, 2036. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. Ultimate completion date is April 10, 2026.

Quick answers

Who was awarded contract SPE2DR26FRRW5?

SPE2DR26FRRW5 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 20, 2026.

How much is contract SPE2DR26FRRW5 worth?

The government has obligated $10,058 on SPE2DR26FRRW5.

Is contract SPE2DR26FRRW5 an order under another contract?

Yes. SPE2DR26FRRW5 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.

Was contract SPE2DR26FRRW5 competed?

The extent of competition for SPE2DR26FRRW5 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award